A recent study indicates that prions, which are misfolded proteins associated with serious brain disorders, may contain short peptides that could serve as antibiotic candidates.
This finding raises the possibility of developing new treatments for infections caused by drug-resistant bacteria, a growing concern in the medical community.
The role of artificial intelligence in this research underscores its potential to facilitate drug discovery and address pressing health challenges.